Cell Therapy Market (By Therapy Type: Autologous, Allogeneic; By Therapeutic Area) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2024-2033

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Cell Therapy Market 

5.1. COVID-19 Landscape: Cell Therapy Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Cell Therapy Market, By Therapy Type

8.1. Cell Therapy Market, by Therapy Type, 2024-2033

8.1.1. Allogeneic Therapies

8.1.1.1. Market Revenue and Forecast (2021-2033)

8.1.2. Autologous Therapies

8.1.2.1. Market Revenue and Forecast (2021-2033)

Chapter 9. Global Cell Therapy Market, By Therapeutic Area

9.1. Cell Therapy Market, by Therapeutic Area, 2024-2033

9.1.1. Oncology

9.1.1.1. Market Revenue and Forecast (2021-2033)

9.1.2. Cardiovascular Disease (CVD)

9.1.2.1. Market Revenue and Forecast (2021-2033)

9.1.3. Musculoskeletal Disorders

9.1.3.1. Market Revenue and Forecast (2021-2033)

9.1.4. Dermatology

9.1.4.1. Market Revenue and Forecast (2021-2033)

9.1.5. Others

9.1.5.1. Market Revenue and Forecast (2021-2033)

Chapter 10. Global Cell Therapy Market, Regional Estimates and Trend Forecast

10.1. North America

10.1.1. Market Revenue and Forecast, by Therapy Type (2021-2033)

10.1.2. Market Revenue and Forecast, by Therapeutic Area (2021-2033)

10.1.3. U.S.

10.1.3.1. Market Revenue and Forecast, by Therapy Type (2021-2033)

10.1.3.2. Market Revenue and Forecast, by Therapeutic Area (2021-2033)

10.1.4. Rest of North America

10.1.4.1. Market Revenue and Forecast, by Therapy Type (2021-2033)

10.1.4.2. Market Revenue and Forecast, by Therapeutic Area (2021-2033)

10.2. Europe

10.2.1. Market Revenue and Forecast, by Therapy Type (2021-2033)

10.2.2. Market Revenue and Forecast, by Therapeutic Area (2021-2033)

10.2.3. UK

10.2.3.1. Market Revenue and Forecast, by Therapy Type (2021-2033)

10.2.3.2. Market Revenue and Forecast, by Therapeutic Area (2021-2033)

10.2.4. Germany

10.2.4.1. Market Revenue and Forecast, by Therapy Type (2021-2033)

10.2.4.2. Market Revenue and Forecast, by Therapeutic Area (2021-2033)

10.2.5. France

10.2.5.1. Market Revenue and Forecast, by Therapy Type (2021-2033)

10.2.5.2. Market Revenue and Forecast, by Therapeutic Area (2021-2033)

10.2.6. Rest of Europe

10.2.6.1. Market Revenue and Forecast, by Therapy Type (2021-2033)

10.2.6.2. Market Revenue and Forecast, by Therapeutic Area (2021-2033)

10.3. APAC

10.3.1. Market Revenue and Forecast, by Therapy Type (2021-2033)

10.3.2. Market Revenue and Forecast, by Therapeutic Area (2021-2033)

10.3.3. India

10.3.3.1. Market Revenue and Forecast, by Therapy Type (2021-2033)

10.3.3.2. Market Revenue and Forecast, by Therapeutic Area (2021-2033)

10.3.4. China

10.3.4.1. Market Revenue and Forecast, by Therapy Type (2021-2033)

10.3.4.2. Market Revenue and Forecast, by Therapeutic Area (2021-2033)

10.3.5. Japan

10.3.5.1. Market Revenue and Forecast, by Therapy Type (2021-2033)

10.3.5.2. Market Revenue and Forecast, by Therapeutic Area (2021-2033)

10.3.6. Rest of APAC

10.3.6.1. Market Revenue and Forecast, by Therapy Type (2021-2033)

10.3.6.2. Market Revenue and Forecast, by Therapeutic Area (2021-2033)

10.4. MEA

10.4.1. Market Revenue and Forecast, by Therapy Type (2021-2033)

10.4.2. Market Revenue and Forecast, by Therapeutic Area (2021-2033)

10.4.3. GCC

10.4.3.1. Market Revenue and Forecast, by Therapy Type (2021-2033)

10.4.3.2. Market Revenue and Forecast, by Therapeutic Area (2021-2033)

10.4.4. North Africa

10.4.4.1. Market Revenue and Forecast, by Therapy Type (2021-2033)

10.4.4.2. Market Revenue and Forecast, by Therapeutic Area (2021-2033)

10.4.5. South Africa

10.4.5.1. Market Revenue and Forecast, by Therapy Type (2021-2033)

10.4.5.2. Market Revenue and Forecast, by Therapeutic Area (2021-2033)

10.4.6. Rest of MEA

10.4.6.1. Market Revenue and Forecast, by Therapy Type (2021-2033)

10.4.6.2. Market Revenue and Forecast, by Therapeutic Area (2021-2033)

10.5. Latin America

10.5.1. Market Revenue and Forecast, by Therapy Type (2021-2033)

10.5.2. Market Revenue and Forecast, by Therapeutic Area (2021-2033)

10.5.3. Brazil

10.5.3.1. Market Revenue and Forecast, by Therapy Type (2021-2033)

10.5.3.2. Market Revenue and Forecast, by Therapeutic Area (2021-2033)

10.5.4. Rest of LATAM

10.5.4.1. Market Revenue and Forecast, by Therapy Type (2021-2033)

10.5.4.2. Market Revenue and Forecast, by Therapeutic Area (2021-2033)

Chapter 11. Company Profiles

11.1. Novartis AG

11.1.1. Company Overview

11.1.2. Product Offerings

11.1.3. Financial Performance

11.1.4. Recent Initiatives

11.2. Gilead Sciences, Inc.

11.2.1. Company Overview

11.2.2. Product Offerings

11.2.3. Financial Performance

11.2.4. Recent Initiatives

11.3. Bristol-Myers Squibb Company

11.3.1. Company Overview

11.3.2. Product Offerings

11.3.3. Financial Performance

11.3.4. Recent Initiatives

11.4. Johnson & Johnson Services, Inc

11.4.1. Company Overview

11.4.2. Product Offerings

11.4.3. Financial Performance

11.4.4. LTE Scientific

11.5. JCR Pharmaceuticals Co., Ltd.

11.5.1. Company Overview

11.5.2. Product Offerings

11.5.3. Financial Performance

11.5.4. Recent Initiatives

11.6. JW Therapeutics

11.6.1. Company Overview

11.6.2. Product Offerings

11.6.3. Financial Performance

11.6.4. Recent Initiatives

11.7. Atara Biotherapeutics

11.7.1. Company Overview

11.7.2. Product Offerings

11.7.3. Financial Performance

11.7.4. Recent Initiatives

11.8. Anterogen Co., Ltd.

11.8.1. Company Overview

11.8.2. Product Offerings

11.8.3. Financial Performance

11.8.4. Recent Initiatives

11.9. MEDIPOST

11.9.1. Company Overview

11.9.2. Product Offerings

11.9.3. Financial Performance

11.9.4. Recent Initiatives

11.10. S. BIOMEDICS

11.10.1. Company Overview

11.10.2. Product Offerings

11.10.3. Financial Performance

11.10.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research

12.2. Secondary Research

12.3. Assumptions

Chapter 13. Appendix

13.1. About Us

13.2. Glossary of Terms

Frequently Asked Questions

The global cell therapy market size was reached at USD 4.77 billion in 2023 and it is projected to hit around USD 36.83 billion by 2033.

The global cell therapy market is growing at a compound annual growth rate (CAGR) of 22.68% from 2024 to 2033.

The North America region has accounted for the largest cell therapy market share in 2023.

Report Details

  • Report Code:37509
  • Category:Healthcare
  • No. of Pages:150+
  • Format:PDF/PPT/Excel
  • Published:February 2024
  • Historical Year:2021-2022
  • Base Year:2023
  • Estimated Year:2024-2033

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers